Stockreport

Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Dogwood Therapeutics, Inc.  (DWTX) 
PDF ATLANTA, March 18, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biotechnology company developing new medicin [Read more]